CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-10-12 | DOMAIN PARTERS VII L P 10% owner | Conversion · Series B Preferred Stock | −1,206,836 | 0 | ||
| 2016-10-12 | DOMAIN PARTERS VII L P 10% owner | Conversion · Series C Preferred Stock | −836,722 | 0 | ||
| 2016-10-12 | DOMAIN PARTERS VII L P 10% owner | Conversion · Series D Preferred Stock | −597,207 | 0 | ||
| 2016-10-12 | DOMAIN PARTERS VII L P 10% owner | Conversion · Series E Preferred Stock | −482,326 | 0 | ||
| 2016-10-12 | Kamdar Kim P. Director | Purchase | +13,400 | $15.00 | $201K | 13,400 |
| 2016-10-12 | Stevenson Sharon Director | Conversion | +190,780 | 190,780 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion | +266,829 | 457,609 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion | +40,995 | 498,604 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion | +161,504 | 161,504 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion | +119,441 | 280,945 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion | +47,629 | 546,233 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion | +60,290 | 341,235 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion · Series A Preferred Stock | −143,677 | 0 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion · Series B Preferred Stock | −266,829 | 0 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion · Series C Preferred Stock | −40,995 | 0 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion · Series C Preferred Stock | −161,504 | 0 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion · Series D Preferred Stock | −119,441 | 0 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion · Series E Preferred Stock | −47,629 | 0 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion · Series E Preferred Stock | −60,290 | 0 | ||
| 2016-10-12 | Stevenson Sharon Director | Conversion · Series C Preferred Stock Warrant (right to buy) | −4,037 | 0 |
Page 16 of 17 · 322 trades